SLC5A2 and urinary bladder carcinoma: A previous study25 analyzing the broad spectrum of safety profiles of SGLT2-Is demonstrated a nonsignificant occurrence of major hypoglycemic events, acute kidney injury, fracture, bladder cancer, Fournier gangrene, amputation, and urinary tract infection but a slightly increased association of diabetic ketoacidosis.